141 related articles for article (PubMed ID: 38505912)
1. A Systems Biology Approach Unveils a Critical Role of DPP4 in Upper Gastrointestinal Cancer Patient Outcomes.
Kotnala S; Dhasmana A; Dhasmana S; Haque S; Yallapu MM; Tripathi MK; Jaggi M; Chauhan SC
J Environ Pathol Toxicol Oncol; 2024; 43(2):43-55. PubMed ID: 38505912
[TBL] [Abstract][Full Text] [Related]
2. Effect of DPP4/CD26 expression on SARS‑CoV‑2 susceptibility, immune response, adenosine (derivatives m
Du J; Fu J; Zhang W; Zhang L; Chen H; Cheng J; He T; Fu J
Int J Oncol; 2023 Mar; 62(3):. PubMed ID: 36799191
[TBL] [Abstract][Full Text] [Related]
3. DPP4/CD26 overexpression in urothelial carcinoma confers an independent prognostic impact and correlates with intrinsic biological aggressiveness.
Liang PI; Yeh BW; Li WM; Chan TC; Chang IW; Huang CN; Li CC; Ke HL; Yeh HC; Wu WJ; Li CF
Oncotarget; 2017 Jan; 8(2):2995-3008. PubMed ID: 27936466
[TBL] [Abstract][Full Text] [Related]
4. CD26/DPP4 - a potential biomarker and target for cancer therapy.
Enz N; Vliegen G; De Meester I; Jungraithmayr W
Pharmacol Ther; 2019 Jun; 198():135-159. PubMed ID: 30822465
[TBL] [Abstract][Full Text] [Related]
5. Dipeptidyl Peptidase IV as a Prognostic Marker and Therapeutic Target in Papillary Thyroid Carcinoma.
Lee JJ; Wang TY; Liu CL; Chien MN; Chen MJ; Hsu YC; Leung CH; Cheng SP
J Clin Endocrinol Metab; 2017 Aug; 102(8):2930-2940. PubMed ID: 28575350
[TBL] [Abstract][Full Text] [Related]
6. The CD26/DPP4-inhibitor vildagliptin suppresses lung cancer growth via macrophage-mediated NK cell activity.
Jang JH; Janker F; De Meester I; Arni S; Borgeaud N; Yamada Y; Gil Bazo I; Weder W; Jungraithmayr W
Carcinogenesis; 2019 Apr; 40(2):324-334. PubMed ID: 30698677
[TBL] [Abstract][Full Text] [Related]
7. Dipeptidyl peptidase IV (DPP4) deficiency increases Th1-driven allergic contact dermatitis.
Tasic T; Bäumer W; Schmiedl A; Schwichtenhövel F; Pabst R; Raap U; von Hörsten S; Stephan M
Clin Exp Allergy; 2011 Aug; 41(8):1098-107. PubMed ID: 21672052
[TBL] [Abstract][Full Text] [Related]
8. Dipeptidyl Peptidase 4 Inhibitors Reduce Hepatocellular Carcinoma by Activating Lymphocyte Chemotaxis in Mice.
Nishina S; Yamauchi A; Kawaguchi T; Kaku K; Goto M; Sasaki K; Hara Y; Tomiyama Y; Kuribayashi F; Torimura T; Hino K
Cell Mol Gastroenterol Hepatol; 2019; 7(1):115-134. PubMed ID: 30510994
[TBL] [Abstract][Full Text] [Related]
9. Genetic variants of dipeptidyl peptidase IV are linked to the clinicopathologic development of prostate cancer.
Wen YC; Lin CY; Hsiao CH; Wang SS; Huang HC; Lin YW; Ho KH; Chang LC; Yang SF; Chien MH
J Cell Mol Med; 2023 Sep; 27(17):2507-2516. PubMed ID: 37533175
[TBL] [Abstract][Full Text] [Related]
10. Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system.
Klemann C; Wagner L; Stephan M; von Hörsten S
Clin Exp Immunol; 2016 Jul; 185(1):1-21. PubMed ID: 26919392
[TBL] [Abstract][Full Text] [Related]
11. Degranulation of human cytotoxic lymphocytes is a major source of proteolytically active soluble CD26/DPP4.
Lettau M; Dietz M; Vollmers S; Armbrust F; Peters C; Dang TM; Chitadze G; Kabelitz D; Janssen O
Cell Mol Life Sci; 2020 Feb; 77(4):751-764. PubMed ID: 31300870
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoids mobilize macrophages by transcriptionally up-regulating the exopeptidase DPP4.
Diaz-Jimenez D; Petrillo MG; Busada JT; Hermoso MA; Cidlowski JA
J Biol Chem; 2020 Mar; 295(10):3213-3227. PubMed ID: 31988243
[TBL] [Abstract][Full Text] [Related]
13. CD26-Related Serum Biomarkers: sCD26 Protein, DPP4 Activity, and Anti-CD26 Isotype Levels in a Colorectal Cancer-Screening Context.
De Chiara L; Páez de la Cadena M; Rodríguez-Berrocal J; Alvarez-Pardiñas MC; Pardiñas-Añón MC; Varela-Calviño R; Cordero OJ
Dis Markers; 2020; 2020():4347936. PubMed ID: 32051696
[TBL] [Abstract][Full Text] [Related]
14. The mechanism of sitagliptin inhibition of colorectal cancer cell lines' metastatic functionalities.
Varela-Calviño R; Rodríguez-Quiroga M; Dias Carvalho P; Martins F; Serra-Roma A; Vázquez-Iglesias L; Páez de la Cadena M; Velho S; Cordero OJ
IUBMB Life; 2021 May; 73(5):761-773. PubMed ID: 33615655
[TBL] [Abstract][Full Text] [Related]
15. Targeting cluster of differentiation 26 / dipeptidyl peptidase 4 (CD26/DPP4) in organ fibrosis.
Ohm B; Moneke I; Jungraithmayr W
Br J Pharmacol; 2023 Nov; 180(22):2846-2861. PubMed ID: 36196001
[TBL] [Abstract][Full Text] [Related]
16. Oxidized LDL upregulates macrophage DPP4 expression via TLR4/TRIF/CD36 pathways.
Rao X; Zhao S; Braunstein Z; Mao H; Razavi M; Duan L; Wei Y; Toomey AC; Rajagopalan S; Zhong J
EBioMedicine; 2019 Mar; 41():50-61. PubMed ID: 30738832
[TBL] [Abstract][Full Text] [Related]
17. Unravelling the immunological roles of dipeptidyl peptidase 4 (DPP4) activity and/or structure homologue (DASH) proteins.
Wagner L; Klemann C; Stephan M; von Hörsten S
Clin Exp Immunol; 2016 Jun; 184(3):265-83. PubMed ID: 26671446
[TBL] [Abstract][Full Text] [Related]
18. Dipeptidyl Peptidase-4 Stabilizes Integrin α4β1 Complex to Promote Thyroid Cancer Cell Metastasis by Activating Transforming Growth Factor-Beta Signaling Pathway.
He Q; Cao H; Zhao Y; Chen P; Wang N; Li W; Cui R; Hou P; Zhang X; Ji M
Thyroid; 2022 Nov; 32(11):1411-1422. PubMed ID: 36166219
[No Abstract] [Full Text] [Related]
19. Anti-inflammatory effects on ischemia/reperfusion-injured lung transplants by the cluster of differentiation 26/dipeptidylpeptidase 4 (CD26/DPP4) inhibitor vildagliptin.
Jang JH; Yamada Y; Janker F; De Meester I; Baerts L; Vliegen G; Inci I; Chatterjee S; Weder W; Jungraithmayr W
J Thorac Cardiovasc Surg; 2017 Mar; 153(3):713-724.e4. PubMed ID: 27939504
[TBL] [Abstract][Full Text] [Related]
20. Serum CD26 levels in patients with gastric cancer: a novel potential diagnostic marker.
Boccardi V; Marano L; Rossetti RR; Rizzo MR; di Martino N; Paolisso G
BMC Cancer; 2015 Oct; 15():703. PubMed ID: 26471376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
